An evaluation of various antiparkinsonian agents as releasing agents and uptake inhibitors for 3H-dopamine in slices of rat neostriatum.
D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology*; D001590:Benztropine / Q000494:pharmacology; D002395:Catecholamines / Q000037:antagonists & inhibitors; D002421:Caudate Nucleus / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D004155:Diphenhydramine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D018492:Dopamine Antagonists; D004305:Dose-Response Relationship, Drug; D009966:Orphenadrine / Q000494:pharmacology; D011699:Putamen / Q000378:metabolism; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D014282:Trihexyphenidyl / Q000494:pharmacology; D014316:Tritium
D000978:Antiparkinson Agents; D002395:Catecholamines; D018492:Dopamine Antagonists; D014316:Tritium; D001590:Benztropine; D012701:Serotonin; D014282:Trihexyphenidyl; D004155:Diphenhydramine; D009966:Orphenadrine; D004298:Dopamine